JoVE Logo

Sign In

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.

In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative deamination can occur, resulting in the formation of simpler amines, such as amphetamine.

Additional transformations can also occur, such as N-oxide formation in basic nitrogen atoms and N-hydroxylation in non-basic nitrogen atoms or those lacking an α-hydrogen.

Carbon-sulfur systems can undergo processes like S-dealkylation, S-alkylation, desulphurization, and S-oxidation. Sulphonamides and thiols, commonly found in various drugs, typically undergo these reactions. In contrast, carbon-oxygen systems predominantly undergo O-dealkylation. A classic example of a drug undergoing this type of reaction is codeine.

In addition to these specific reactions, there are also miscellaneous oxidative reactions. For example, reductive dehalogenation can occur in fluorocarbons like halothane, and the reduction of sulfur-containing groups can be seen in drugs like disulfiram. Understanding these complex biochemical reactions is critical in the pharmaceutical industry. Researchers and healthcare professionals can design and administer safer and more effective therapies by understanding how different compounds interact with the body's metabolic processes.

Tags

Phase I ReactionsOxidative ReactionsCarbon heteroatom SystemsCarbon nitrogen SystemsAliphatic AminesN dealkylationOxidative DeaminationCarbon sulfur SystemsS oxidationSulphonamidesO dealkylationCodeineMiscellaneous Oxidative ReactionsReductive DehalogenationPharmaceutical Industry

From Chapter 5:

article

Now Playing

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

50 Views

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

218 Views

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

215 Views

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

122 Views

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

163 Views

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

52 Views

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

129 Views

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

191 Views

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

141 Views

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

120 Views

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

145 Views

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

102 Views

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

31 Views

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

138 Views

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

85 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved